The Natural and Non-prescription Health Products Directorate (NNHPD) will published the following 5 monographs on April 25, 2025. CA’s running list of monograph updates may be found here.
Monographs not in batches
- Pseudoephedrine_ Adolescents 12-17 years and Adults
- Pseudoephedrine_Children 6-11 years
- Borage oil
- Flaxseed oil
- Eleuthero
As a reminder, product licence holders are expected to align impacted products with monograph revisions per section 7.2 of the Natural Health Products Management of Applications Policy.
Minor revisions to monographs previously updated:
NNHPD have made minor revisions to the following 3 monographs:
Caffeine:
- Adjustment of the Class II and III combination note to revise ‘400 mg or more’ to ‘more than 400 mg’ of total caffeine per day cannot make any claims other than the ones listed on this monograph.
- Inclusion of the information ‘synthetic’ for the source ingredients.
- Revisions of typos in the French version.
Counterirritants:
- Adjustment of the Class II and III combination note to add ‘along with evidence to support their safety and efficacy’ in the sentence ‘Theses products may be submitted as a Class III application along with evidence to support their safety and efficacy’.
- Revision of the frequency ‘up to 3-4 times per day’ to ‘up to 4 times per day’.
Acne therapy:
- Revision of a typo in the HTML English version only in the claim ‘Reduces the number and/or severity of acne pimples (and allows skin to heal)’ (publication date not updated as the PDF versions were accurate).
